Patents by Inventor Howard DOONG

Howard DOONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • extract for the treatment of attention-deficit hyperactivity disorder
    Patent number: 11857592
    Abstract: This invention relates to a method of treating Attention-Deficit Hyperactivity Disorder by orally administering to a subject a composition containing a Radix Polygalae (Polygala tenuifolia Willd) extract (such as PDC-1421). A solid dosage form of the composition can be prepared into the gelatin capsule. The oral administration of the composition in healthy volunteers was safe and well-tolerated for the daily dose from 380 mg to 3800 mg. The composition can be administered chronically over at least 25 days; the daily dose is administered once per day, twice per day, or three times per day, wherein each dose is 380-760 mg of the botanical extract.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: January 2, 2024
    Assignee: BIOLITE, INC.
    Inventors: Chi-Hsin Richard King, Hsien-Ming Wu, Howard Doong, Tsung-Shann Jiang
  • extract for the treatment of major depressive disorder
    Patent number: 11554154
    Abstract: This invention relates to a method of treating Major depressive disorder by orally administering to a subject a composition containing a Radix Polygalae (Polygala tenuifolia Willd) extract (PDC-1421). A solid dosage form of PDC-1421 can be prepared into the gelatin capsule. The oral administration of PDC-1421 in healthy volunteers was safe and well-tolerated for the daily dose from 380 mg to 3800 mg. The composition can be administered chronically over at least 25 days; the daily dose is administered once per day, twice per day, or three times per day, wherein each dose is 380-760 mg of the botanical extraction.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: January 17, 2023
    Assignee: BIOLITE, INC.
    Inventors: Chi-Hsin Richard King, Hsien-Ming Wu, Howard Doong, Tsung-Shann Jiang
  • POLYGALA EXTRACT FOR THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    Publication number: 20220184167
    Abstract: This invention relates to a method of treating Attention-Deficit Hyperactivity Disorder by orally administering to a subject a composition containing a Radix Polygalae (Polygala tenuifolia Willd) extract (such as PDC-1421). A solid dosage form of the composition can be prepared into the gelatin capsule. The oral administration of the composition in healthy volunteers was safe and well-tolerated for the daily dose from 380 mg to 3800 mg. The composition can be administered chronically over at least 25 days; the daily dose is administered once per day, twice per day, or three times per day, wherein each dose is 380-760 mg of the botanical extract.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 16, 2022
    Inventors: Chi-Hsin Richard KING, Hsien-Ming WU, Howard DOONG, Tsung-Shann JIANG
  • POLYGALA EXTRACT FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Publication number: 20220023373
    Abstract: This invention relates to a method of treating Major depressive disorder by orally administering to a subject a composition containing a Radix Polygalae (Polygala tenuifolia Willd) extract (PDC-1421). A solid dosage form of PDC-1421 can he prepared into the gelatin capsule. The oral administration of PDC-1421 in healthy volunteers was safe and well-tolerated for the daily dose from 380 mg to 3800 mg. The composition can be administered chronically over at least 25 days; the daily dose is administered once per day, twice per day, or three times per day, wherein each dose is 380-760 mg of the botanical extraction.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 27, 2022
    Inventors: Chi-Hsin Richard KING, Hsien-Ming WU, Howard DOONG, Tsung-Shann JIANG